When investors ask about your moat, they are not asking why you are winning now. They are asking what stops the next well-capitalized competitor from taking your position the moment it becomes worth taking. Most things founders call moats are not.
A better product is not a moat; products get copied. Being first is not a moat; fast followers routinely win. A great team is an advantage but not a barrier. These help you win the first round, but a moat is about the second and third, when someone with more money and a copy of your playbook shows up. The test is durability against a serious competitor, not superiority today.
Durable moats tend to come in a few forms: network effects, where the product gets more valuable as more people use it; high switching costs, where leaving is painful; economies of scale that a new entrant cannot match; and regulatory or licensing barriers that take years and expertise to clear. What they share is that they compound over time and cannot be bought quickly.
A licensing footprint, a clean examination history, and a compliance program a regulator already trusts are earned on the regulator's calendar and cannot be compressed with capital. That is why we invest where the regulatory moat is deepest: it is one of the few barriers a better-funded competitor genuinely cannot shortcut. This is general information, not investment advice.
A moat is measured against the next competitor, not the last.